Dataset Information

UWHVF: A Real-World, Open Source Dataset of Perimetry Tests From the Humphrey Field Analyzer at the University of Washington.

ABSTRACT:

Purpose

This article describes the Humphrey field analyzer (HFA) dataset from the Department of Ophthalmology at the University of Washington.

Methods

Pointwise sensitivities were extracted from HFA 24-2, stimulus III visual fields (VF). Total deviation (TD), mean TD (MTD), pattern deviation, and pattern standard deviation (PSD) were calculated. Progression analysis was performed with simple linear regression on global, regional, and pointwise values for VF series with greater than four tests spanning at least four months. VF data were extracted independently of clinical information except for patient age, gender, and laterality.

Results

This dataset includes 28,943 VFs from 7248 eyes of 3871 patients. Progression was calculated for 2985 eyes from 1579 patients. Median [interquartile range] age was 64 years [54, 73], and follow-up was 2.49 years [1.11, 5.03]. Baseline MTD was -4.51 dB [-8.01, -2.65], and baseline PSD was 2.41 dB [1.7, 5.34].

Conclusion

MTD was found to decrease by -0.10 dB/yr [-0.40, 0.11] in eyes for which progression analysis was able to be performed. VFs with deep localized defects, PSD > 12 dB and MTD -15 dB to -25 dB, were plotted, visually inspected, and found to be consistent with neurologic or glaucomatous VFs from patients. For a small number of tests, extracted sensitivity values were compared to corresponding printouts and confirmed to match.

Translational relevance

This open access pointwise VF dataset serves as a source of raw data for investigation such as VF behavior, clinical comparisons to trials, and development of new machine learning algorithms.

SUBMITTER: Montesano G

PROVIDER: S-EPMC8742531 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:PurposeTo compare visual fields on the Nidek MP-1 to those obtained on the Humphrey field analyzer (HFA) in healthy volunteers and assess the effects of differences in stimulus parameters and testing strategies that may influence the interpretation of results in patients. A secondary aim was to establish MP-1 normative data to calculate the total deviation analyses and global indices analogous to those used by the HFA.MethodsFifty healthy volunteers (age 43.5 ± 13.9 years, range, 18 to 68 years) underwent repeat MP-1 and HFA visual field testing, using the 10-2 pattern. MP-1 data were converted to HFA equivalent dB units. Between instrument comparisons of HFA and MP-1 sensitivities, regression of sensitivity with age and examination duration were assessed. Test-retest variability was examined between visits.ResultsMP-1 (mean = 32.82 dB, SD = 1.92 dB) and HFA sensitivities (mean = 32.84 dB, SD = 1.83 dB) were not significantly different (p = 0.759). SD values for the HFA (range, 1.11 to 3.30 dB) were similar to the MP-1 (range, 0.14 to 2.75 dB). However, asymmetry comparisons between instruments showed significantly decreased superior rather than inferior retinal values for the MP-1. There was a small but significant difference (p = 0.004) in mean test duration between the MP-1 (mean = 6:11 min, SD = 1:49 min) and the HFA (mean = 5:14 min, SD = 0:42 min). There was also a difference in the decline of mean sensitivity with age, a decline of 0.1 and 0.4 dB per decade was noted in MP-1 and HFA sensitivity, respectively. Test-retest variability was similar between instruments. A small but non-significant increase in mean sensitivity at the second visit for both the MP-1 (p = 0.060) and HFA (p = 0.570) was found.ConclusionsBoth instruments showed similar variability and test-retest variability when results were compared using equivalent units. However, there are important differences in sensitivity values, stimulus parameters, and testing strategies that have to be taken into account when comparisons are made.

Project description:This data was generated by ENCODE. If you have questions about the data, contact the submitting laboratory directly (Richard Sandstrom mailto:sull@u.washington.edu). If you have questions about the Genome Browser track associated with this data, contact ENCODE (mailto:genome@soe.ucsc.edu). This track contains chromatin interaction data from the University of Washington ENCODE group generated using 5C (Chromatin Conformation Capture Carbon Copy). The 5C method is used here to define short and long-range range interactions between transcription start sites (TSS) and DNaseI hypersensitive sites (DHS) or other genomic features. The 5C method is summarized below. Transcription factors bind to promoter-associated proteins, bringing the associated DNA sequences in close proximity to each other. Cross linking the DNA and proteins immobilizes these interactions and thus maintains their close proximity. Cleavage of the sample with restriction endonuclease followed by ligation results in hybrid molecules where a fragment with a regulatory element is physically associated with a fragment containing a TSS. The interactions are then detected by oligonucleotide-dependent, ligation-mediated assays, where one set of primers is complementary to the end of fragments with a TSS and the second set of primers are complementary to fragments with a feature. Primers are designed to the forward strand of the feature and the reverse strand of the TSS so that ligation only occurs between TSS and feature, not between different features. Specific interactions are detected by massively parallel sequencing. The data in this track comprises two different experiment types focusing on targeted regions: Gene-targeted project: Analysis of DNase I hypersensitive sites reveals many genes where there are multiple sites restricted to the cell type where a protein is observed to be expressed. These sites potentially identify regulatory sites for the gene. This set of experiments attempts to observe interactions between these DHS sites and transcription starts in 25 regions selected based on genes expressed in GM06990 (B-lymphocyte), BJ (foreskin fibroblast), HepG2 (liver cancer cell line), or SK-N-SH_RA (neuroblastoma cell line, SKNSH, differentiated with retinoic acid). Myc project: Genome wide association studies have identified SNPs linked to prostate, colon, and breast cancer in the gene desert region upstream of the myc gene. 5C of HindIII fragments interacting with those containing refSeq txStarts in this region were performed in 5 cell types: GM12878 (B-lymphocyte), CaCo2 (colon cancer cell line), LNCaP (prostate cancer cell line), MCF7 (breast cancer cell line), and K562 (erythroleukemia cell line). For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODEDataReleasePolicyFinal2008.pdf

Project description:BackgroundTo conduct a preliminary evaluation of the feasibility of visual field fast (VFF), a free iPad-based noise-field perimeter, in detecting glaucomatous scotomas versus the clinical-standard Humphrey visual field (HVF) test. VFF confronts subjects with a screen of flickering stimulus, allowing the immediate perception of scotomas.MethodsThis was a cross-sectional observational study of 66 glaucoma patients (66 eyes) and 30 healthy controls (30 eyes). All patients had no other visual field disorders. VFF was compared against HVF in terms of whole field and quadrants for the following: (1) correspondence in scotoma detection. (2) Agreement and correlation of the scotoma size (percentage of abnormal visual field area). (3) Test duration. Other domains tested included: (1) correlation of VFF scotoma area with the severity of visual field loss on HVF (mean deviation, MD; visual field index, VFI). (2) Repeatability of VFF. (3) Patient descriptors of scotomas.ResultsUsing HVF pattern deviation plot as a reference, VFF detected 52/57 (91.2%) of glaucoma subjects with 1 false-positive (control) (kappa = 0.86). 146/184 (79.3%) of abnormal quadrants (visual field defect present) were localized and 23/157 (14.6%) healthy quadrants were falsely identified as abnormal (kappa = 0.61). VFF underestimated scotoma area as compared to HVF (21.0% versus 44.0%, p < 0.01) but correlated positively (r = 0.268, p = 0.044) with HVF area and negatively with VFI (r = -0.340, p = 0.01) and MD (r = -0.398, p < 0.01). Using HVF total deviation plot as reference, VFF's glaucoma detection rate remained unchanged (kappa = 0.86) with similar quadrant detection (kappa = 0.68). However, a greater underestimation of scotoma area was observed (21.0% versus 85.4%, p < 0.01). VFF's quantitative repeatability was excellent for whole field (intraclass correlation coefficient, ICC: 0.96; p < 0.0001) and quadrants (ICC: 0.82-0.96; all p < 0.001). Qualitatively, 35/37 (94.6%) of subjects reported reduced luminance and flicker in scotomas, with similar morphologies on retests. VFF is faster than HVF SITA-Standard in glaucoma (3.60 ± 1.85 min versus 6.92 ± 1.12 min, p < 0.01) and control (1.12 ± 0.486 min versus 5.16 ± 0.727 min, p < 0.01).ConclusionThis early model of VFF accurately detected scotomas with high repeatability. However, its accuracy in localizing and quantifying the scotoma can be improved. Considering its portability and cost-effectiveness, VFF demonstrated potential as a general screening tool for moderate-to-severe glaucoma.